Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists

被引：17
|
作者：
Kant, Sam [1 ]
Kronbichler, Andreas [2 ]
Salas, Antonio [1 ]
Bruchfeld, Annette [3 ,4 ]
Geetha, Duvuru [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA
[2] Med Univ Innsbruck, Dept Internal Med Nephrol & Hypertens 4, Innsbruck, Austria
[3] Karolinska Univ Hosp, Dept Renal Med, Stockholm, Sweden
[4] CLINTEC Karolinska Inst, Stockholm, Sweden
来源：
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 05期
关键词：
anti-CD20; COVID-19; vaccine;
D O I：
10.1016/j.ekir.2021.03.876
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1197 / 1199
页数：3
相关论文
共 50 条
  • [21] Updated Results of the COVID-19 in MS Global Data Sharing Initiative Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
    Simpson-Yap, Steve
    Pirmani, Ashkan
    Kalincik, Tomas
    De Brouwer, Edward
    Geys, Lotte
    Parciak, Tina
    Helme, Anne
    Rijke, Nick
    Hillert, Jan A.
    Moreau, Yves
    Edan, Gilles
    Sharmin, Sifat
    Spelman, Tim
    McBurney, Robert
    Schmidt, Hollie
    Bergmann, Arnfin B.
    Braune, Stefan
    Stahmann, Alexander
    Middleton, Rod M.
    Salter, Amber
    Bebo, Bruce
    van der Walt, Anneke
    Butzkueven, Helmut
    Ozakbas, Serkan
    Boz, Cavit
    Karabudak, Rana
    Alroughani, Raed
    Rojas, Juan, I
    van der Mei, Ingrid A.
    do Olival, Guilherme Sciascia
    Magyari, Melinda
    Alonso, Ricardo N.
    Nicholas, Richard S.
    Chertcoff, Anibal S.
    de Torres, Ana Zabalza
    Arrambide, Georgina
    Nag, Nupur
    Descamps, Annabel
    Costers, Lars
    Dobson, Ruth
    Miller, Aleisha
    Rodrigues, Paulo
    Prckovska, Vesna
    Comi, Giancarlo
    Peeters, Liesbet M.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (06):
  • [22] Response to COVID-19 mRNA Vaccination in Patients with Multiple Sclerosis on anti-CD20 Disease Modifying Therapies
    Wolf, Andrew
    Pratt, Robert W.
    Crooks, Kristy
    Borko, Tyler
    Gonzalez, Jose Parra
    Vollmer, Timothy
    Frazer-Abel, Ashley
    ANNALS OF NEUROLOGY, 2021, 90 : S179 - S180
  • [23] COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients
    Kasten, Mary J.
    Lahr, Brian D.
    Parisapogu, Anusha
    Yetmar, Zachary A.
    O'Horo, John C.
    Orenstein, Robert
    Moreno Franco, Pablo
    Razonable, Raymund R.
    Vergidis, Paschalis
    Shah, Aditya S.
    Enzler, Mark J.
    Inwards, David J.
    Bauer, Philippe R.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [24] The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment
    Komlodi-Pasztor, Edina
    Escarra-Senmarti, Marta
    Bazer, Danielle A.
    Bhatnagar, Aastha
    Perez Heydrich, Carlos A.
    Messmer, Marcus
    Ambinder, Richard F.
    Gladstone, Douglas E.
    Clayton, Laura
    Goodrich, Amy
    Schoch, Laura
    Wagner-Johnston, Nina
    VandenBussche, Christopher J.
    Huang, Peng
    Holdhoff, Matthias
    Rosario, Maximillian
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [25] COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients
    Mary J. Kasten
    Brian D. Lahr
    Anusha Parisapogu
    Zachary A. Yetmar
    John C. O’Horo
    Robert Orenstein
    Pablo Moreno Franco
    Raymund R. Razonable
    Paschalis Vergidis
    Aditya S. Shah
    Mark J. Enzler
    David J. Inwards
    Philippe R. Bauer
    Scientific Reports, 13
  • [26] Casirivimab/Imdevimab for Active COVID-19 Pneumonia Which Persisted for Nine Months in a Patient with Follicular Lymphoma during Anti-CD20 Therapy
    Nagai, Hiroyuki
    Saito, Makoto
    Adachi, Eisuke
    Sakai-Tagawa, Yuko
    Yamayoshi, Seiya
    Kiso, Maki
    Kawamata, Toyotaka
    Koga, Michiko
    Kawaoka, Yoshihiro
    Tsutsumi, Takeya
    Yotsuyanagi, Hiroshi
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2022, 75 (06) : 608 - 611
  • [27] Development of anti-CD20 therapy for multiple sclerosis
    Bartok, Beatrix
    Silverman, Gregg J. J.
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) : 1312 - 1318
  • [28] Anti-CD20 Therapy: Underutilizing A Seed for Success?
    Camargo, Alyssa
    Squire, Jacqueline
    Rank, Matthew
    Freeman, Catherine
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S53 - S53
  • [29] Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
    Houot, Roch
    Levy, Ronald
    Cartron, Guillaume
    Armand, Philippe
    EUROPEAN JOURNAL OF CANCER, 2020, 136 : 4 - 6
  • [30] Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
    Masashi Nishikubo
    Yoshimitsu Shimomura
    Ryusuke Yamamoto
    Satoshi Yoshioka
    Hayato Maruoka
    Seiko Nasu
    Tomomi Nishioka
    Kenji Sakizono
    Satoshi Mitsuyuki
    Tomoyo Kubo
    Naoki Okada
    Daishi Nakagawa
    Kimimori Kamijo
    Hiroharu Imoto
    Yuya Nagai
    Nobuhiro Hiramoto
    Noboru Yonetani
    Tadakazu Kondo
    Chisato Miyakoshi
    Asako Doi
    Takayuki Ishikawa
    Blood Cancer Journal, 13
12345